{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:18:57Z","timestamp":1788315537487,"version":"build-2803163510"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","license":[{"start":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T00:00:00Z","timestamp":1540857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1104756"],"award-info":[{"award-number":["OPP1104756"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,30]]},"DOI":"10.1093\/cid\/ciy603","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T07:54:56Z","timestamp":1533542096000},"page":"S42-S50","source":"Crossref","is-referenced-by-count":25,"title":["Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine\/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine\u2013only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chilean Infants"],"prefix":"10.1093","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0280-2288","authenticated-orcid":false,"given":"Elizabeth B","family":"Brickley","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Wieland-Alter","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Dartmouth-Hitchcock Medical Center, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth I","family":"Connor","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret E","family":"Ackerman","sequence":"additional","affiliation":[{"name":"Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin W","family":"Boesch","sequence":"additional","affiliation":[{"name":"Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minetaro","family":"Arita","sequence":"additional","affiliation":[{"name":"Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C","family":"Weldon","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel G","family":"O\u2019Ryan","sequence":"additional","affiliation":[{"name":"Microbiology and Mycology Program and Millennium Institute of Immunology and Immunotherapy, Faculty of Medicine, University of Chile, Santiago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananda S","family":"Bandyopadhyay","sequence":"additional","affiliation":[{"name":"Bill & Melinda Gates Foundation, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F","family":"Wright","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Dartmouth-Hitchcock Medical Center, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,30]]},"reference":[{"key":"key\n\t\t\t\t2018103001004228700_CIT0001","volume-title":"Semi-annual status report: January to June 2016","author":"Global Polio Eradication Initiative","year":"2016"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0002"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0003","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1093\/infdis\/jiu184","article-title":"Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden","volume":"210","author":"Platt","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0004","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1093\/infdis\/jiu295","article-title":"Vaccine-derived polioviruses","volume":"210","author":"Burns","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0005","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2217\/fmb.15.19","article-title":"Polio vaccination: past, present and future","volume":"10","author":"Bandyopadhyay","year":"2015","journal-title":"Future Microbiol"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0006","doi-asserted-by":"crossref","first-page":"S434","DOI":"10.1093\/infdis\/jiu222","article-title":"The new polio eradication end game: rationale and supporting evidence","volume":"210","author":"Sutter","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0007","first-page":"27","article-title":"The elimination of polio in the Scandinavian countries","volume":"21","author":"B\u00f6ttiger","year":"1993","journal-title":"Public Health Rev"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0008","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/infdis\/jix556","article-title":"Intestinal immune responses to type 2 oral polio vaccine (OPV) challenge in infants previously immunized with bivalent OPV and either high-dose or standard inactivated polio vaccine","volume":"217","author":"Brickley","year":"2018","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0009","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S1473-3099(16)30169-4","article-title":"Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants","volume":"16","author":"Wright","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0010","doi-asserted-by":"crossref","first-page":"e1002599","DOI":"10.1371\/journal.ppat.1002599","article-title":"Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge","volume":"8","author":"Hird","year":"2012","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0011","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1093\/infdis\/175.Supplement_1.S228","article-title":"Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules","volume":"175","author":"Modlin","year":"1997","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0012","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1056\/NEJMoa054960","article-title":"Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba","volume":"356","author":"Cuba IPVSCG","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0013","article-title":"Mucosal immunity: the forgotten arm of the immune system: synopsis of the Pediatric Infectious Disease Society\u2019s 2017 Stanley A. Plotkin lecture in vaccinology. J Pediatric Infect Dis Soc 2017; pix102. doi:10.1093\/jpids\/pix102","author":"Wright"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0014","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1473-3099(15)00219-4","article-title":"Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study","volume":"15","author":"O\u2019Ryan","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0015","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/infdis\/jit671","article-title":"Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination","volume":"209","author":"Wright","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0016","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1128\/CVI.05225-11","article-title":"Development of a poliovirus neutralization test with poliovirus pseudovirus for measurement of neutralizing antibody titer in human serum","volume":"18","author":"Arita","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0017","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4939-3292-4_8","article-title":"Standardized methods for detection of poliovirus antibodies","volume":"1387","author":"Weldon","year":"2016","journal-title":"Methods Mol Biol"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0018","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(16)00703-0","article-title":"Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial","volume":"388","author":"Asturias","year":"2016","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0019","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S1473-3099(17)30236-0","article-title":"Maximising the impact of inactivated polio vaccines","volume":"17","author":"Brickley","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0020"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0021","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/cid\/ciu1136","article-title":"Genetic analysis and characterization of wild poliovirus type 1 during sustained transmission in a population with >95% vaccine coverage, Israel 2013","volume":"60","author":"Shulman","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0022","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1086\/498172","article-title":"Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains","volume":"192","author":"Laassri","year":"2005","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0023","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S1473-3099(17)30358-4","article-title":"Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study","volume":"17","author":"Taniuchi","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0024","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1126\/science.1130388","article-title":"New strategies for the elimination of polio from India","volume":"314","author":"Grassly","year":"2006","journal-title":"Science"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0025","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1126\/science.1255006","article-title":"Polio eradication. Efficacy of inactivated poliovirus vaccine in India","volume":"345","author":"Jafari","year":"2014","journal-title":"Science"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0026","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(14)60934-X","article-title":"Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial","volume":"384","author":"John","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0027","article-title":"The duration of intestinal immunity after an inactivated poliovirus vaccine booster dose in children immunized with oral vaccine: a randomized controlled trial. J Infect Dis 2017; 215:529\u201336. doi:10.1093\/infdis\/jiw595","author":"John"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0028","doi-asserted-by":"crossref","first-page":"e0146010","DOI":"10.1371\/journal.pone.0146010","article-title":"Human circulating antibody-producing B cell as a predictive measure of mucosal immunity to poliovirus","volume":"11","author":"Dey","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0029","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.vaccine.2013.11.056","article-title":"Oral polio vaccine response in breast fed infants with malnutrition and diarrhea","volume":"32","author":"Haque","year":"2014","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0030","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1542\/peds.101.2.242","article-title":"Modulation of the immune system by human milk and infant formula containing nucleotides","volume":"101","author":"Pickering","year":"1998","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0031","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.jpeds.2009.11.014","article-title":"The mucosal immune system and its integration with the mammary glands","volume":"156","author":"Brandtzaeg","year":"2010","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0032","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/jamapediatrics.2015.3732","article-title":"Association of Cesarean delivery and formula supplementation with the intestinal microbiome of 6-week-old infants","volume":"170","author":"Madan","year":"2016","journal-title":"JAMA Pediatr"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0033","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nature17940","article-title":"Development of the gut microbiota and mucosal IgA responses in twins and gnotobiotic mice","volume":"534","author":"Planer","year":"2016","journal-title":"Nature"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0034","first-page":"217","article-title":"Detection of MEF-1 laboratory reference strain of poliovirus type 2 in children with poliomyelitis in India in 2002 & 2003","volume":"118","author":"Deshpande","year":"2003","journal-title":"Indian J Med Res"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0035","article-title":"Risk assessment, risk management and risk-based monitoring following a reported accidental release of poliovirus in Belgium, September to November 2014. Euro Surveill. 2016;21:pii=30169. doi:10.2807\/1560-7917.ES.2016.21.11.30169","author":"Duizer"},{"key":"key\n\t\t\t\t2018103001004228700_CIT0036","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.vaccine.2015.01.018","article-title":"Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication","volume":"33","author":"Guo","year":"2015","journal-title":"Vaccine"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/67\/suppl_1\/S42\/26189904\/ciy603.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T17:58:33Z","timestamp":1571680713000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/67\/suppl_1\/S42\/5146683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,30]]},"references-count":36,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2018,10,30]]},"published-print":{"date-parts":[[2018,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy603","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11,15]]},"published":{"date-parts":[[2018,10,30]]}}}